IPXL
Impax Laboratories, Inc.
IPXL
IPXL
Delisted
IPXL was delisted on the 4th of May, 2018.
181 hedge funds and large institutions have $1.45B invested in Impax Laboratories, Inc. in 2014 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 71 increasing their positions, 61 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
181
Holders Change
+15
Holders Change %
+9.04%
% of All Funds
5.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
34
Increased
71
Reduced
61
Closed
18
Calls
$8.63M
Puts
$5.18M
Net Calls
+$3.45M
Net Calls Change
+$1.9M
Top Buyers
| 1 |
O
OrbiMed
New York
|
$141M |
| 2 |
Millennium Management
New York
|
$31.3M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
$10.7M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
$12.9M |
| 5 |
PC
PointState Capital
New York
|
$9.25M |
